Eroxon Stimgel

Eroxon is a breakthrough medical device in the form of a topical gel used for the treatment of erectile dysfunction. Developed by Futura Medical plc, a pharmaceutical company based in the United Kingdom, it works through a unique physical cooling and warming action that stimulates nerve endings.

The product is manufactured primarily in Belgium through specialized pharmaceutical contractors. While Futura Medical holds the research and intellectual property rights, they have entered into significant global distribution agreements to bring the product to market.

In recent years, the brand has seen expansion through a major partnership with Haleon, a global leader in consumer health. Haleon, which was spun off from GSK and is headquartered in the UK, serves as the ultimate owner/distributor for the product in major markets including the United States, managing its commercialization and retail presence globally.